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Scoring for the Legs
P. De Rango*
Unit of Vascular and Endovascular Surgery, Hospital S. M. Misericordia, S. Andrea delle Fratte, 06129 Perugia, ItalyRecent expansion of endovascular techniques for the treatment
of infrapopliteal artery disease has increased the expectation to
realistically provide a safer, easier, quicker and effective therapy for
many patients with critical limb ischaemia (CLI). Nevertheless, due
to the limited numbers, spread among a variety of different tech-
niques, centres and diseases (extension and severity) and the
recent introduction (not allowing to validate durability of the
results), these novel approaches have still not proved to substan-
tially improve outcomes and remain under investigation in ongoing
studies. Periprocedural risk exposure and predictability of success/
failure for the leg with these new approaches in CLI patients remain
largely uncertain. Failure rate of distal leg revascularisation tech-
niques relies on several factors (location, extension and severity of
artery lesion, run-off status, plantar arch integrity, calciﬁcation,
diabetes, local status, infection, gangrene, etc.) or, most likely, on
a combination of these. A number of scoring systems have been
usefully applied to predict outcome after aortic aneurysm or cardiac
surgery, while similar methods are lacking in the more challenging
ﬁeld of revascularisation in the legs, with only a few recently
conceived.1 In this issue of EJVES, a Japanese experience from Iida
et al. proposed a new anatomical score to predict the 2-year major
adverse limb event (MALE), deﬁned as freedom from major
amputation or any re-intervention after angioplasty of isolated
infrapopliteal lesions in patients with CLI.2 By using this score
system adopted from cardiac experience (SYNTAX angiographic
score for coronary vessel)3 and thereby including only anatomical
predictability criteria, the authors were able to individuate limbs
with infrapopliteal lesions at high likelihood of unsuccessful
endovascular treatment. According to Iida et al. lesion calciﬁcation,
target vessel diameter <3.0 mm, lesion length >300 mm and no
below-the-ankle run-off were positively associated with MALE by
multivariate analysis. Over a total of 1057 infrapopliteal angioplasty
procedures, freedom fromMALE at 2 years rates were 59% in limbs
with only one of these adverse risk factors, but only 29% for limbs
with three or four adverse predictors.
Even though the authors tested exclusively simple balloon
angioplasty and nomore sophisticated techniques for infrapopliteal
revascularisation, their system scoremay help identify legs with CLI
that can improve less from endovascular therapy and should beDOI of original article: 10.1016/j.ejvs.2012.05.011.
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assigned to medical therapy alone. Multiple unsuccessful revascu-
larisation procedures and related recurrent/prolonged read-
missions are indeed known risk factors with a major impact in
increasing morbidity and decreasing the quality of life in CLI
patients.
The score for treatment of infrapopiteal lesions of Iida et al.
suggests that selection of a procedure for revascularisation should
be based more on anatomic features (i.e., whether the patient
satisﬁes anatomic criteria for endovascular treatment) than on
demographic or clinical features. Nevertheless, concerns remain
regarding the lack of any patient-related clinical information in the
Iida et al. study. Indeed, for the coronary angiographic SYNTAX
score (from which the Japanese score was derived), the ultimate
goal was to create an angiographic tool to predict prognosis based
on disease complexity in coronary vessels, with the primary end
point of a composite of major adverse cardiac events (MACEs)
including death from cardiac causes and myocardial infarction (MI)
in addition to ischaemia-driven target lesion revascularisation
(TLR).3 In the Japanese score, the survival risks were focussed only
on the leg (amputation or revascularisation) and not on the
patients. Even though mortality risk may directly occur after
a coronary intervention (as for the SYNTAX population) rather than
after a leg procedure, the co-morbid setting of patients with CLI
should raise the question on the suitability of interventional risk
exposure that cannot be ignored. CLI patients constitute a ‘frail’
population with multiple co-morbidities and increased burden of
mortality (especially cardiovascular mortality), morbidity and poor
functional outcome. The opportunity to apply an invasive treat-
ment (even if minimally invasive), especially if potentially repeti-
tive and partially effective, in patients with advanced CLI is
challenging because of the higher procedure-related risk exposure
and the uncertain probability to reverse an often enduring
advanced disease of the distal leg. Scoring systems to predict
success of treatment for leg survival in CLI settings should be aware
also of the patient and not only of limbs outcome.References
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